Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-14-303313
Filing Date
2014-08-08
Accepted
2014-08-08 17:09:56
Documents
10
Period of Report
2014-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d736423d10q.htm 10-Q 339325
2 EX-31.1 d736423dex311.htm EX-31.1 9194
3 EX-31.2 d736423dex312.htm EX-31.2 9189
4 EX-32.1 d736423dex321.htm EX-32.1 4117
  Complete submission text file 0001193125-14-303313.txt   4231936

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT ampe-20140630.xml EX-101.INS 526883
6 XBRL TAXONOMY EXTENSION SCHEMA ampe-20140630.xsd EX-101.SCH 49735
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ampe-20140630_cal.xml EX-101.CAL 47115
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ampe-20140630_def.xml EX-101.DEF 231835
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE ampe-20140630_lab.xml EX-101.LAB 388278
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ampe-20140630_pre.xml EX-101.PRE 312061
Mailing Address 5445 DTC PARKWAY SUITE 925 GREENWOOD VILLAGE CO 80111
Business Address 5445 DTC PARKWAY SUITE 925 GREENWOOD VILLAGE CO 80111 720-437-6500
Ampio Pharmaceuticals, Inc. (Filer) CIK: 0001411906 (see all company filings)

EIN.: 260179592 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35182 | Film No.: 141028293
SIC: 2834 Pharmaceutical Preparations